BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 20, 2008
View Archived Issues
Novel cPLA2 alpha inhibitor presented at the ACS meeting
Read More
GSK-189254 shows in vivo efficacy against neuropathic, but not inflammatory, pain
Read More
AS-006 effective in vivo against inflammatory pain
Read More
AMRI initiates phase I study of tubulin inhibitor ALB-109564(a) in advanced solid tumors
Read More
Watson successfully completes pilot clinical study of Stellar's Uracyst in interstitial cystitis
Read More
FDA and Medco sign partnership to study pharmacogenetic testing of prescription drugs
Read More
Omeros and Affitech enter agreement for fully human antibodies for MASP-2
Read More
Leo Pharmaceuticals receives European approval for Xamiol for scalp psoriasis
Read More
Repros presents an update on phase II endometriosis study of Proellex
Read More
Regeneron and Bayer HealthCare announce results from a phase II study of VEGF Trap-Eye
Read More
Allergan divulges new therapeutic agents for glaucoma in a recent patent
Read More
Recent Panacea Biotec patent discloses novel antibacterial agents
Read More
Schering-Plough launches asthma inhaler Asmanex Twisthaler in the U.S.
Read More
New agents for treating neurological disorders described in recent patent literature
Read More
Transplantation of islet cells with Sertoli cells may be feasible for diabetes treatment
Read More
Further PROMISE data show efficacy of voclosporin in renal transplantation
Read More
Pfizer's PDE10A inhibitor PF-254920 may be useful for the treatment of schizophrenia
Read More
Vical's Vaxfectin adjuvant to be tested with preventive DNA vaccine against HIV
Read More
Bristol-Myers Squibb and PDL enter global alliance in multiple myeloma
Read More
Cel-Sci enters exclusive licensing agreement with Teva for cancer drug Multikine
Read More
Neurologix starts recruitment in phase II gene transfer trial in Parkinson's disease
Read More
Viralytics doses second patient group in Cavatak phase I melanoma trial
Read More
